<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Low Prevalence Antigens | Blood Bank</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Low-prevalence antigens (LPA) are the rare counterparts to common blood group markers. While finding compatible blood for patients with antibodies to LPAs is generally straightforward, the primary...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Low Prevalence Antigens | Blood Bank">
<meta property="og:type" content="book">
<meta property="og:description" content="Low-prevalence antigens (LPA) are the rare counterparts to common blood group markers. While finding compatible blood for patients with antibodies to LPAs is generally straightforward, the primary...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Low Prevalence Antigens | Blood Bank">
<meta name="twitter:description" content="Low-prevalence antigens (LPA) are the rare counterparts to common blood group markers. While finding compatible blood for patients with antibodies to LPAs is generally straightforward, the primary...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><link rel="icon" type="image/png" href="imgs/favicon.png">
<meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
<link rel="stylesheet" href="toc.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Blood Bank</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Blood Products</li>
<li><a class="" href="donors.html">Donors</a></li>
<li><a class="" href="qualification.html">Qualification</a></li>
<li><a class="" href="processing.html">Processing</a></li>
<li><a class="" href="adverse-reactions-1.html">Adverse Reactions</a></li>
<li><a class="" href="special-donations-1.html">Special Donations</a></li>
<li><a class="" href="processing-1.html">Processing</a></li>
<li><a class="" href="fda-aabb-requirements.html">FDA, AABB Requirements</a></li>
<li><a class="" href="testing.html">Testing</a></li>
<li><a class="" href="labeling.html">Labeling</a></li>
<li><a class="" href="storage.html">Storage</a></li>
<li><a class="" href="anticoagulantsadditives.html">Anticoagulants/Additives</a></li>
<li><a class="" href="temperature-requirements.html">Temperature Requirements</a></li>
<li><a class="" href="transportation.html">Transportation</a></li>
<li><a class="" href="stored-products.html">Stored Products</a></li>
<li><a class="" href="expiration.html">Expiration</a></li>
<li><a class="" href="blood-components.html">Blood Components</a></li>
<li><a class="" href="red-blood-cells.html">Red Blood Cells</a></li>
<li><a class="" href="cryoprecipitated-ahf.html">Cryoprecipitated AHF</a></li>
<li><a class="" href="platelets.html">Platelets</a></li>
<li><a class="" href="plasma.html">Plasma</a></li>
<li><a class="" href="granulocytes.html">Granulocytes</a></li>
<li><a class="" href="wbc-reduced-components.html">WBC-Reduced Components</a></li>
<li><a class="" href="frozendeglycerolized-rbcs.html">Frozen/Deglycerolized RBCs</a></li>
<li><a class="" href="apheresis-products.html">Apheresis Products</a></li>
<li><a class="" href="fractionation-products.html">Fractionation Products</a></li>
<li><a class="" href="whole-blood.html">Whole Blood</a></li>
<li><a class="" href="washed-rbcs.html">Washed RBCs</a></li>
<li><a class="" href="rejuvenated-rbcs.html">Rejuvenated RBCs</a></li>
<li><a class="" href="irradiated-components.html">Irradiated Components</a></li>
<li><a class="" href="hematopoietic-progenitors.html">Hematopoietic Progenitors</a></li>
<li><a class="" href="blood-component-qc.html">Blood Component QC</a></li>
<li class="book-part">Blood Group Systems</li>
<li><a class="" href="genetics.html">Genetics</a></li>
<li><a class="" href="basic.html">Basic</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="blood-group-inheritance.html">Blood Group Inheritance</a></li>
<li><a class="" href="biochemistryantigens.html">Biochemistry/Antigens</a></li>
<li><a class="" href="abo.html">ABO</a></li>
<li><a class="" href="lewis.html">Lewis</a></li>
<li><a class="" href="rh.html">Rh</a></li>
<li><a class="" href="mns.html">MNS</a></li>
<li><a class="" href="p1pkglobosidep.html">P1PK/Globoside(P)</a></li>
<li><a class="" href="ii.html">Ii</a></li>
<li><a class="" href="kell.html">Kell</a></li>
<li><a class="" href="kidd.html">Kidd</a></li>
<li><a class="" href="duffy.html">Duffy</a></li>
<li><a class="" href="lutheran.html">Lutheran</a></li>
<li><a class="" href="other-blood-groups.html">Other Blood Groups</a></li>
<li><a class="" href="high-prevalence-antigens.html">High Prevalence Antigens</a></li>
<li><a class="active" href="low-prevalence-antigens.html">Low Prevalence Antigens</a></li>
<li><a class="" href="hla.html">HLA</a></li>
<li><a class="" href="platelet-specific.html">Platelet-Specific</a></li>
<li><a class="" href="granulocyte-specific.html">Granulocyte-Specific</a></li>
<li><a class="" href="role-of-blood-groups-in-transfusion.html">Role of Blood Groups in Transfusion</a></li>
<li><a class="" href="immunogenicity.html">Immunogenicity</a></li>
<li><a class="" href="antigen-prevalence.html">Antigen Prevalence</a></li>
<li class="book-part">Immunology &amp; Physiology</li>
<li><a class="" href="immunology.html">Immunology</a></li>
<li><a class="" href="immune-response.html">Immune response</a></li>
<li><a class="" href="primary-secondary.html">Primary &amp; Secondary</a></li>
<li><a class="" href="b-t-cells-macrophages.html">B &amp; T cells, Macrophages</a></li>
<li><a class="" href="genetics-1.html">Genetics</a></li>
<li><a class="" href="immunoglobulins.html">Immunoglobulins</a></li>
<li><a class="" href="classes-subclasses.html">Classes &amp; Subclasses</a></li>
<li><a class="" href="structure.html">Structure</a></li>
<li><a class="" href="properties.html">Properties</a></li>
<li><a class="" href="ag-ab-interactions.html">Ag-Ab Interactions</a></li>
<li><a class="" href="principles.html">Principles</a></li>
<li><a class="" href="testing-1.html">Testing</a></li>
<li><a class="" href="complement.html">Complement</a></li>
<li><a class="" href="pathway-mechanisms.html">Pathway Mechanisms</a></li>
<li><a class="" href="biologic-properties.html">Biologic Properties</a></li>
<li><a class="" href="physiology-pathophysiology.html">Physiology &amp; Pathophysiology</a></li>
<li><a class="" href="blood-physiology.html">Blood Physiology</a></li>
<li><a class="" href="circulation-volume.html">Circulation &amp; Volume</a></li>
<li><a class="" href="composition-function.html">Composition &amp; Function</a></li>
<li><a class="" href="cell-survival.html">Cell Survival</a></li>
<li><a class="" href="cell-metabolism.html">Cell Metabolism</a></li>
<li><a class="" href="hemostasis-coagulation.html">Hemostasis &amp; Coagulation</a></li>
<li><a class="" href="factors-disorders.html">Factors &amp; Disorders</a></li>
<li><a class="" href="plt-functions-disorders.html">PLT Functions &amp; Disorders</a></li>
<li><a class="" href="hdfn.html">HDFN</a></li>
<li><a class="" href="pathophysiology.html">Pathophysiology</a></li>
<li><a class="" href="detection.html">Detection</a></li>
<li><a class="" href="treatment.html">Treatment</a></li>
<li><a class="" href="prevention.html">Prevention</a></li>
<li><a class="" href="cytopenias-1.html">Cytopenias</a></li>
<li><a class="" href="anemia.html">Anemia</a></li>
<li><a class="" href="thrombocytopenia.html">Thrombocytopenia</a></li>
<li><a class="" href="neutropenia.html">Neutropenia</a></li>
<li><a class="" href="transplantation-1.html">Transplantation</a></li>
<li><a class="" href="solid-organ.html">Solid Organ</a></li>
<li><a class="" href="hpc.html">HPC</a></li>
<li class="book-part">Serology &amp; Molecular</li>
<li><a class="" href="routine-tests.html">Routine Tests</a></li>
<li><a class="" href="blood-grouping.html">Blood Grouping</a></li>
<li><a class="" href="compatibility.html">Compatibility</a></li>
<li><a class="" href="antibody-detection.html">Antibody Detection</a></li>
<li><a class="" href="crossmatch.html">Crossmatch</a></li>
<li><a class="" href="ab-id-significance.html">Ab ID &amp; Significance</a></li>
<li><a class="" href="dat.html">DAT</a></li>
<li><a class="" href="reagents.html">Reagents</a></li>
<li><a class="" href="antiglobulin-sera.html">Antiglobulin Sera</a></li>
<li><a class="" href="blood-grouping-sera.html">Blood Grouping Sera</a></li>
<li><a class="" href="reagent-rbcs.html">Reagent RBCs</a></li>
<li><a class="" href="special-tests-reagents.html">Special Tests &amp; Reagents</a></li>
<li><a class="" href="enzymes.html">Enzymes</a></li>
<li><a class="" href="enhancement-media.html">Enhancement Media</a></li>
<li><a class="" href="lectins.html">Lectins</a></li>
<li><a class="" href="adsorptions.html">Adsorptions</a></li>
<li><a class="" href="elutions.html">Elutions</a></li>
<li><a class="" href="titrations-1.html">Titrations</a></li>
<li><a class="" href="cell-separations.html">Cell Separations</a></li>
<li><a class="" href="elisa.html">ELISA</a></li>
<li><a class="" href="molecular-techniques.html">Molecular Techniques</a></li>
<li><a class="" href="neutralization.html">Neutralization</a></li>
<li><a class="" href="thiol-reagents.html">Thiol Reagents</a></li>
<li><a class="" href="immunofluorescence.html">Immunofluorescence</a></li>
<li><a class="" href="solid-phase.html">Solid Phase</a></li>
<li><a class="" href="column-agglutination.html">Column Agglutination</a></li>
<li><a class="" href="chloroquine-diphosphate.html">Chloroquine Diphosphate</a></li>
<li><a class="" href="edta-glycine-acid.html">EDTA-Glycine Acid</a></li>
<li><a class="" href="quality-assurance.html">Quality Assurance</a></li>
<li><a class="" href="blood-samples.html">Blood Samples</a></li>
<li><a class="" href="reagents-1.html">Reagents</a></li>
<li><a class="" href="test-procedures.html">Test Procedures</a></li>
<li class="book-part">Transfusion Practice</li>
<li><a class="" href="indications.html">Indications</a></li>
<li><a class="" href="component-therapy.html">Component Therapy</a></li>
<li><a class="" href="adverse-effects.html">Adverse Effects</a></li>
<li><a class="" href="immunologic.html">Immunologic</a></li>
<li><a class="" href="nonimmunologic.html">Nonimmunologic</a></li>
<li><a class="" href="ttds.html">TTDs</a></li>
<li><a class="" href="apheresis-extracorporeal-circulation.html">Apheresis &amp; Extracorporeal Circulation</a></li>
<li><a class="" href="blood-administration-patient-blood-management.html">Blood Administration &amp; Patient Blood Management</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="low-prevalence-antigens" class="section level1 unnumbered">
<h1>Low Prevalence Antigens<a class="anchor" aria-label="anchor" href="#low-prevalence-antigens"><i class="fas fa-link"></i></a>
</h1>
<p><strong>Low-prevalence antigens</strong> (LPA) are the rare counterparts to common blood group markers. While finding compatible blood for patients with antibodies to LPAs is generally straightforward, the primary challenge lies in the initial detection and identification of these often-elusive antibodies, <strong>frequently revealed only by an incompatible crossmatch</strong>. Their clinical significance varies and must be evaluated individually</p>
<p>While antibodies to high-prevalence antigens create a <em>finding compatible blood</em> crisis, antibodies to low-prevalence antigens present a different set of challenges, primarily around their initial <em>detection</em> and confirmation</p>
<div id="antigens-of-low-prevalence-the-rarities" class="section level2 unnumbered">
<h2>
<strong>Antigens of Low Prevalence: The Rarities</strong><a class="anchor" aria-label="anchor" href="#antigens-of-low-prevalence-the-rarities"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> A low-prevalence antigen (LPA), sometimes called a “private” antigen, is a red blood cell surface antigen expressed by only a small percentage of a given population, typically ranging from &lt;0.1% up to maybe 10%, depending on the specific antigen and population</li>
<li>
<strong>Biochemical Basis:</strong> Like all blood group antigens, LPAs arise from genetic variations (often SNPs) that alter the structure of proteins or glycoproteins on the red cell surface, or modify carbohydrate structures. Many LPAs are the antithetical partners to high-prevalence antigens (e.g., K is the LPA partner to the high-prevalence k antigen)</li>
</ul>
</div>
<div id="key-characteristics-and-implications" class="section level2 unnumbered">
<h2>
<strong>Key Characteristics and Implications</strong><a class="anchor" aria-label="anchor" href="#key-characteristics-and-implications"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Antibody Frequency:</strong> Because the antigen is rare, exposure through transfusion or pregnancy is uncommon. Therefore, antibodies to LPAs are also relatively <strong>infrequently encountered</strong> in routine testing</li>
<li>
<strong>Antibody Detection Challenge:</strong> This is the main issue. When a patient <em>does</em> form an antibody to an LPA:
<ul>
<li>It will likely be <strong>non-reactive with standard antibody screening cells</strong>, as these cells are usually chosen to represent common antigen profiles and will likely lack the specific LPA</li>
<li>It may react with <strong>only one cell on a larger identification panel</strong>, if that panel happens to include a cell positive for the rare antigen. This single reaction can sometimes be dismissed as insignificant or difficult to interpret</li>
<li>The antibody might only be detected during the <strong>crossmatch phase</strong> if the selected donor unit happens to be positive for the specific LPA the patient has an antibody against. This is a classic cause of an “unexpected incompatible crossmatch” with a negative antibody screen</li>
</ul>
</li>
<li>
<strong>Finding Compatible Blood:</strong> This is generally <strong>EASY</strong>. Since the antigen is rare, the vast majority of random donors will be antigen-negative and therefore compatible (assuming the antibody has been correctly identified)</li>
<li>
<strong>Clinical Significance:</strong> Varies widely! Some antibodies to LPAs are <strong>clinically significant</strong> and capable of causing HTR and HDFN (e.g., anti-K, anti-Js<sup>a</sup>, anti-Wr<sup>a</sup>), while others are considered insignificant or have low clinical relevance. Significance must be assessed for each specific antibody</li>
</ul>
</div>
<div id="examples-of-important-low-prevalence-antigens" class="section level2 unnumbered">
<h2>
<strong>Examples of Important Low-Prevalence Antigens</strong><a class="anchor" aria-label="anchor" href="#examples-of-important-low-prevalence-antigens"><i class="fas fa-link"></i></a>
</h2>
<p>Many LPAs are the less common partner in an antithetical pair within major blood group systems</p>
<div id="k-kell---kell-system-kel-isbt-006" class="section level3 unnumbered">
<h3>
<strong>K (Kell) - Kell System (KEL, ISBT 006)</strong><a class="anchor" aria-label="anchor" href="#k-kell---kell-system-kel-isbt-006"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Biochemistry:</strong> Kell glycoprotein</li>
<li>
<strong>Prevalence:</strong> ~9% in Caucasians, ~2% in Black populations. Antithetical to k (high prevalence)</li>
<li>
<strong>Antibody (Anti-K):</strong> IgG, <strong>highly clinically significant</strong> (can cause severe HTR and HDFN). One of the most common clinically significant antibodies outside of ABO/Rh</li>
<li>
<strong>Antigen-Positive:</strong> K+k+ or K+k- individuals</li>
</ul>
</div>
<div id="kpa-penney---kell-system-kel-isbt-006" class="section level3 unnumbered">
<h3>
<strong>Kp<sup>a</sup> (Penney) - Kell System (KEL, ISBT 006)</strong><a class="anchor" aria-label="anchor" href="#kpa-penney---kell-system-kel-isbt-006"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Biochemistry:</strong> Kell glycoprotein</li>
<li>
<strong>Prevalence:</strong> ~2% in Caucasians, very rare in Black populations. Antithetical to Kp<sup>b</sup> (high prevalence)</li>
<li>
<strong>Antibody (Anti-Kp<sup>a</sup>):</strong> IgG, clinically significant (HTR, HDFN)</li>
<li>
<strong>Antigen-Positive:</strong> Kp(a+b+) or Kp(a+b-) individuals</li>
</ul>
</div>
<div id="jsa-sutter---kell-system-kel-isbt-006" class="section level3 unnumbered">
<h3>
<strong>Js<sup>a</sup> (Sutter) - Kell System (KEL, ISBT 006)</strong><a class="anchor" aria-label="anchor" href="#jsa-sutter---kell-system-kel-isbt-006"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Biochemistry:</strong> Kell glycoprotein</li>
<li>
<strong>Prevalence:</strong> ~20% in Black populations, very rare (&lt;0.1%) in Caucasians. Antithetical to Js<sup>b</sup> (high prevalence in Caucasians)</li>
<li>
<strong>Antibody (Anti-Js<sup>a</sup>):</strong> IgG, clinically significant (HTR, HDFN)</li>
<li>
<strong>Antigen-Positive:</strong> Js(a+b+) or Js(a+b-) individuals</li>
</ul>
</div>
<div id="lua---lutheran-system-lu-isbt-005" class="section level3 unnumbered">
<h3>
<strong>Lu<sup>a</sup> - Lutheran System (LU, ISBT 005)</strong><a class="anchor" aria-label="anchor" href="#lua---lutheran-system-lu-isbt-005"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Biochemistry:</strong> Lutheran glycoprotein (BCAM)</li>
<li>
<strong>Prevalence:</strong> ~8% in Caucasians, less common in other populations. Antithetical to Lu<sup>b</sup> (high prevalence)</li>
<li>
<strong>Antibody (Anti-Lu<sup>a</sup>):</strong> Often IgM or mixed IgM/IgG, often naturally occurring. Can cause mild HTR, HDFN usually mild or absent. Known for characteristic loose/mixed-field agglutination</li>
<li>
<strong>Antigen-Positive:</strong> Lu(a+b+) or Lu(a+b-) individuals</li>
</ul>
</div>
<div id="dia---diego-system-di-isbt-010" class="section level3 unnumbered">
<h3>
<strong>Di<sup>a</sup> - Diego System (DI, ISBT 010)</strong><a class="anchor" aria-label="anchor" href="#dia---diego-system-di-isbt-010"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Biochemistry:</strong> Located on Band 3 protein (Anion Exchanger 1)</li>
<li>
<strong>Prevalence:</strong> Low prevalence in Caucasians and Black populations (&lt;0.1%), but significantly higher (up to 36% or more) in <strong>Native American and East Asian populations</strong>. Antithetical to Di<sup>b</sup> (high prevalence)</li>
<li>
<strong>Antibody (Anti-Di<sup>a</sup>):</strong> IgG, clinically significant (HTR, HDFN). Importance varies geographically</li>
<li>
<strong>Antigen-Positive:</strong> Di(a+b+) or Di(a+b-) individuals</li>
</ul>
</div>
<div id="wra-wright---diego-system-di-isbt-010" class="section level3 unnumbered">
<h3>
<strong>Wr<sup>a</sup> (Wright) - Diego System (DI, ISBT 010)</strong><a class="anchor" aria-label="anchor" href="#wra-wright---diego-system-di-isbt-010"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Biochemistry:</strong> Requires Band 3 protein</li>
<li>
<strong>Prevalence:</strong> ~0.1% in Caucasians. Antithetical to Wr<sup>b</sup> (high prevalence)</li>
<li>
<strong>Antibody (Anti-Wr<sup>a</sup>):</strong> Can be IgM or IgG, naturally occurring or immune stimulated. <strong>Clinically significant</strong> (can cause severe HTR, HDFN). Sometimes seen as an autoantibody</li>
<li>
<strong>Antigen-Positive:</strong> Wr(a+b+) or Wr(a+b-) individuals</li>
</ul>
</div>
<div id="cob---colton-system-co-isbt-015" class="section level3 unnumbered">
<h3>
<strong>Co<sup>b</sup> - Colton System (CO, ISBT 015)</strong><a class="anchor" aria-label="anchor" href="#cob---colton-system-co-isbt-015"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Biochemistry:</strong> Located on Aquaporin-1 (water channel)</li>
<li>
<strong>Prevalence:</strong> ~10% in Caucasians. Antithetical to Co<sup>a</sup> (high prevalence)</li>
<li>
<strong>Antibody (Anti-Co<sup>b</sup>):</strong> IgG, clinically significant (HTR, HDFN)</li>
<li>
<strong>Antigen-Positive:</strong> Co(a+b+) or Co(a-b+) individuals</li>
</ul>
</div>
<div id="other-examples" class="section level3 unnumbered">
<h3>
<strong>Other Examples</strong><a class="anchor" aria-label="anchor" href="#other-examples"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>V (MNS System):</strong> Low prevalence overall, but higher in Black populations (~30%)</li>
<li>
<strong>M<sup>g</sup> (MNS System):</strong> Low prevalence antigen associated with specific GPA variants. Anti-M<sup>g</sup> can be significant</li>
<li>
<strong>Various antigens within the Miltenberger subsystem (MNS System):</strong> A complex group of LPAs resulting from rearrangements of <em>GYPA</em>, <em>GYPB</em>, and <em>GYPE</em> genes</li>
<li>
<strong>Sc2 (Scianna System):</strong> Low prevalence (~1%), antithetical to Sc1 (high prevalence). Anti-Sc2 can cause HTR/HDFN</li>
</ul>
</div>
</div>
<div id="challenges-and-management-1" class="section level2 unnumbered">
<h2>
<strong>Challenges and Management</strong><a class="anchor" aria-label="anchor" href="#challenges-and-management-1"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Identification:</strong> Requires testing patient plasma/serum against panel cells <em>known</em> to be positive for various LPAs. This is often done in a reference laboratory setting. Testing family members can sometimes help if the antibody specificity is suspected but unconfirmed</li>
<li>
<strong>Crossmatching:</strong> A serological crossmatch remains crucial. It’s the final check and the most likely place to detect an antibody to an LPA if the antibody screen was negative</li>
<li>
<strong>Transfusion:</strong> If an antibody to an LPA is identified and considered clinically significant, antigen-negative blood should be provided. As noted, this is usually readily available</li>
<li>
<strong>HDFN:</strong> If a pregnant person has an antibody to an LPA, the father of the baby should be phenotyped (or genotyped) for the antigen. If he is positive, the fetus is at risk of inheriting the antigen and developing HDFN</li>
</ul>
</div>
<div id="key-terms-42" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-42"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Low-Prevalence Antigen (LPA):</strong> An antigen found on the red blood cells of only a small percentage (typically &lt;10%, often much lower) of a given population. Also sometimes called a “private” antigen</li>
<li>
<strong>Antithetical Antigen:</strong> One of a pair of antigens encoded by alleles at the same gene locus (e.g., K and k, Lu<sup>a</sup> and Lu<sup>b</sup>). Often, if one is high prevalence, the other is low prevalence</li>
<li>
<strong>Crossmatch:</strong> A laboratory test performed before transfusion to determine serological compatibility between donor red blood cells and patient plasma/serum. It serves as a final check for unexpected antibodies, including those against low-prevalence antigens potentially missed by antibody screening</li>
<li>
<strong>Antibody Screen (Antibody Detection Test):</strong> A test using reagent red blood cells with known, common antigen profiles to detect the presence of unexpected antibodies in patient plasma/serum. May miss antibodies to low-prevalence antigens if the screening cells lack the specific antigen</li>
<li>
<strong>Reference Laboratory (Immunohematology Reference Laboratory - IRL):</strong> A specialized laboratory with the resources (rare reagents, extensive panels, molecular capabilities) and expertise to identify complex antibodies, including those directed against low-prevalence antigens</li>
<li>
<strong>Clinically Significant (Antibody):</strong> An antibody capable of causing adverse reactions to transfusion (Hemolytic Transfusion Reactions - HTR) or causing Hemolytic Disease of the Fetus and Newborn (HDFN). Antibodies to some low-prevalence antigens (like K, Wr<sup>a</sup>) are significant, while others may not be</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();

  // hide those labes that take up multiple lines
  sections = [];
  topics = [];
  function hide_label() {
    // sections
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          elem.classList
          .contains('book-part')
          ? sections.push(elem)
          : '';
      });

    // topics
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          !elem.classList
          .contains('book-part')
          ? topics.push(elem)
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    // sections
    count_sections = 0;
    prev_sections_elem = '';
    sections
      .forEach((elem) => {
      if(count_sections === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count_sections = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_sections_elem.classList.add('hide_label');
        } else {
          prev_sections_elem.classList.remove('hide_label');
        }
      }
      prev_sections_elem = elem;
    });
    // topics
    count_topics = 0;
    prev_topic_elem = '';
    topics
      .forEach((elem) => {
      if(count_topics === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count_topics = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_topic_elem.classList.add('hide_label');
        } else {
          prev_topic_elem.classList.remove('hide_label');
        }
      }
      prev_topic_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="high-prevalence-antigens.html">High Prevalence Antigens</a></div>
<div class="next"><a href="hla.html">HLA</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#low-prevalence-antigens">Low Prevalence Antigens</a></li>
<li><a class="nav-link" href="#antigens-of-low-prevalence-the-rarities">Antigens of Low Prevalence: The Rarities</a></li>
<li><a class="nav-link" href="#key-characteristics-and-implications">Key Characteristics and Implications</a></li>
<li>
<a class="nav-link" href="#examples-of-important-low-prevalence-antigens">Examples of Important Low-Prevalence Antigens</a><ul class="nav navbar-nav">
<li><a class="nav-link" href="#k-kell---kell-system-kel-isbt-006">K (Kell) - Kell System (KEL, ISBT 006)</a></li>
<li><a class="nav-link" href="#kpa-penney---kell-system-kel-isbt-006">Kpa (Penney) - Kell System (KEL, ISBT 006)</a></li>
<li><a class="nav-link" href="#jsa-sutter---kell-system-kel-isbt-006">Jsa (Sutter) - Kell System (KEL, ISBT 006)</a></li>
<li><a class="nav-link" href="#lua---lutheran-system-lu-isbt-005">Lua - Lutheran System (LU, ISBT 005)</a></li>
<li><a class="nav-link" href="#dia---diego-system-di-isbt-010">Dia - Diego System (DI, ISBT 010)</a></li>
<li><a class="nav-link" href="#wra-wright---diego-system-di-isbt-010">Wra (Wright) - Diego System (DI, ISBT 010)</a></li>
<li><a class="nav-link" href="#cob---colton-system-co-isbt-015">Cob - Colton System (CO, ISBT 015)</a></li>
<li><a class="nav-link" href="#other-examples">Other Examples</a></li>
</ul>
</li>
<li><a class="nav-link" href="#challenges-and-management-1">Challenges and Management</a></li>
<li><a class="nav-link" href="#key-terms-42">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/blob/main/Rmd/02-B-13.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/edit/main/Rmd/02-B-13.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-04-08 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
